Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Radiation Injuries × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Ovarian Neoplasms 13 Neoplasm Metastasis 11 Prostatic Neoplasms 8 Neoplasms 8 Pancreatic Neoplasms 7 Triple Negative Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Advanced Solid Tumors 4 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Squamous Cell 3 Solid Tumors 2 Sarcoma 2 Neuroendocrine Tumors 2 Lymphoma 2 Hodgkin Disease 2 Fanconi Anemia, Complementation Group D1 2 Endometrial Neoplasms 2 Advanced Solid Tumours 2 Advanced Solid Tumor 2 Triple Negative Metastatic Breast Cancer 1 Thymoma 1 Thrombocytosis 1 Solid Tumor 1 Smoking 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1

Interventions

Radiotherapy 2 olaparib 1 Radiosurgery 1 Poly A 1 Mental Status and Dementia Tests 1 Lithium Carbonate 1 Lithium 1 Linseed Oil 1 Ipilimumab 1 Adenosine Diphosphate Ribose 1 Adenosine Diphosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03109080 2025-11-24

RadioPARP

Institut Curie

Phase 1 Completed

Radiation Injuries, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡